Table 1

Baseline patient demographics

No of patients57
No of eyes71
Laterality, # cases (%)
 Right39 (54.9)
 Left32 (45.1)
Gender, # patients (%)
 Male30 (52.6)
 Female27 (47.4)
Age in years: median (mean±D)47 (45.77±11.8)
Ethnicity, # patients (%)
 White28 (49.1)
 African American20 (35.1)
 Asian0 (0.0)
 Hispanic7 (12.3)
 Other2 (3.5)
Diabetes classification, # patients (%)
 Type 120 (35.1)
 Type 237 (64.9)
 Insulin-dependent diabetes47 (82.5)
Diabetes severity parameters
 Preoperative A1C (%): median (mean±SD)8.85 (9.02±2.20)
 Duration of diabetes (years): median (mean±SD)20 (19.25±8.81)
 Duration of insulin use (years): median (mean±SD)13 (14.73±11.60)
Medical comorbidities, # patients (%)
 Hypertension46 (80.7)
 Dialysis2 (3.5)
 Peripheral vascular disease12 (21.1)
 Major adverse cardiovascular event13 (22.8)
 Other end organ damage27 (47.4)
History of ophthalmic interventions, # patients (%)
 Panretinal photocoagulation37 (64.9)
 Anti-VEGF injections21 (47.4)
Baseline visual characteristics
 Preoperative logMAR (Snellen equivalent): median (mean±SD)1.30 (20/400)
(1.53 (20/678) ± 0.75 (20/112))
Baseline anatomic characteristics, # cases (%)
 Total detachment11 (15.5)
 Macular detachment23 (31.0)
 Extramacular detachment24 (33.8)
 Vitreoretinal traction only14 (19.7)
Follow-up in months: median (mean±SD)15 (16.99±9.64)